Lemierre Syndrome: A Diagnosis behind the Veil

Table 1

Pertinent laboratory investigations during second ED visit and upon admission to the MICU.

	Units	ED visit 2	MICU admission	Reference interval
White blood cells	/L	18.78 × 10(9)	11.69 × 10(9)	3.50–10.50/L
Red blood cells	/L	4.35 × 10(12)	4.36 × 10(12)	4.32–5.72/L
Hemoglobin	g/dL	13.3	12.9	13.5–17.5 g/dL
Hematocrit	%	38.3	38.2%	38.8–50.0%)
Platelets	/L	128 × 10(9)	114 × 10(9)	150–450/L
Sodium	mmol/L	139	136	136–145 mmol/L
Potassium	mmol/L	4.2	3.3	3.5–5.1 mmol/L
Chloride	mmol/L	100	101	98–107 mmol/L
Bicarbonate	mmol/L	26	24	22–29 mmol/L
Blood urea nitrogen	mg/dL	16	19	6–20 mmol/L
Creatinine, standardized	mg/dL	1.14	1.11	0.70–1.20 mg/dL
Glucose	mg/dL	142	150	70–139 mg/dL
C-reactive protein	mg/dL	23.74		0–0.05 ng/mL
Procalcitonin	ng/mL	31.90		0–0.05 ng/mL
Ferritin	ng/mL	628		30–400 ng/mL
Lactic acid	Mmol/L		3.2	0.5–2.2 mmol/L
Human immunodeficiency virus 1,2 antigen antibody		Nonreactive		Nonreactive
Monospot		Negative	329	Negative
Influenza A and B rapid point of care		Negative	0.28	Negative
SARS-CoV-2 by nucleic acid amplification test polymerase chain reaction		Negative		Negative
SARS-CoV-2 Ab, IgG, and IgM		Reactive		Nonreactive